The object-oriented paradigm popularized by languages including Java and C++ has slowly given way to a functional programming ...

Recursion Pharmaceuticals has agreed to acquire the Oxford, U.K.-based artificial intelligence (AI) drug pioneer Exscientia, the ...

Chris Gibson, PhD, Recursion’s co-founder and CEO, discusses exclusively with GEN Edge his company’s ambitious plans to ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.

Recursion Pharmaceuticals uses AI to improve the process of discovering and developing drugs, making it easier and more cost ...

The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career ...

Can Recursion accelerate the time frame for drug discovery? Last year, Recursion announced that tech giant Nvidia invested $50 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or ...